Article
Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci.
Antimicrobial agents and chemotherapy - 1 Aug 2000
Guerin F, Varon E, Hoï A B, Gutmann L, Podglajen I
Abstract excerpt
Oropharyngeal samples from 60 hospitalized patients (30 fluoroquinolone [FQ]-treated and 30 non-FQ-treated patients) and 30 untreated nonhospitalized healthy control subjects yielded 20 isolates of viridans group streptococci with reduced susceptibility to FQ, mostly from the hospitalized patient...
Topics
- Anti-Infective Agents
- Biological Transport, Active
- DNA Topoisomerases, Type I
- Drug Resistance, Microbial
- Fluoroquinolones
- Humans
- Microbial Sensitivity Tests
- Molecular Sequence Data
- Mutation
- Oropharynx
- Streptococcus
